The relationship between cannabis and schizophrenia: a genetically informed perspective
Abstract
Background and Aims: While epidemiological studies support a role for heavy, high‐potency cannabis use on first‐episode psychosis, genetic models of causation suggest reverse causal effects of schizophrenia on cannabis use liability. We estimated the genetic relationship between cannabis use disorder (CUD) and schizophrenia (SCZ) and tested whether liability for CUD is causally associated with increased liability to SCZ while adjusting for tobacco smoking. Design: This study used summary statistics from published genome‐wide association studies (GWAS). We used genomic structural equation modeling, latent causal variable analysis, and multivariable Mendelian randomization to examine genetic relationships between CUD, cannabis ever‐use, ever‐smoked tobacco regularly, nicotine dependence and SCZ, and to test for a causal relationship between liability to CUD and liability to SCZ. Setting: Genome‐wide association studies were published previously as part of international consortia. Participants: Sample sizes of the GWAS summary statistics used in this study ranged from 161 405 to 357 806 individuals of European ancestry. Measurements: Genome‐wide summary statistics for CUD and SCZ were the primary measurements, while summary statistics for cannabis ever‐use, ever‐smoked tobacco regularly and nicotine dependence were included as additional variables in the genomic structural equation models and the multivariable Mendelian randomization analyses. Findings: Genetic liability to CUD was significantly associated with SCZ [β = 0.29, 95% confidence interval (CI) = 0.11, 0.46, P = 0.001], even when accounting for cannabis ever‐use, ever‐smoked tobacco regularly and nicotine dependence as simultaneous predictors. We found mixed evidence of a causal relationship, with the latent causal variable analysis finding no evidence of causality (genetic causality proportion = −0.08, 95% CI = −0.40, 0.23, P = 0.87) but the multivariable Mendelian randomization analyses suggesting a significant, risk‐increasing effect of CUD on liability to SCZ (β = 0.10, 95% CI = 0.02, 0.18, P = 0.02), accounting for the additional risk factors (cannabis ever‐use, ever‐smoked tobacco regularly and nicotine dependence). Conclusions: Genetic liability for cannabis use disorder appears to be robustly associated with schizophrenia, above and beyond tobacco smoking and cannabis ever‐use, with mixed evidence to support a causal relationship between cannabis use disorder and schizophrenia.Keywords
Funding Information
- National Institute of Mental Health (MH109532)
- National Institute on Alcohol Abuse and Alcoholism (F32AA027435)
- National Institute on Alcohol Abuse and Alcoholism (T32AA028259)
- National Institute on Drug Abuse (K02DA032573)
- National Institute on Drug Abuse (R21DA047527)
This publication has 20 references indexed in Scilit:
- Extending the MR‐Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropyStatistics in Medicine, 2017
- Cannabis use and risk of schizophrenia: a Mendelian randomization studyMolecular Psychiatry, 2017
- Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization studyPsychological Medicine, 2016
- Bias due to participant overlap in two‐sample Mendelian randomizationGenetic Epidemiology, 2016
- No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to QuitFrontiers in Psychiatry, 2016
- Association Between Cannabis and Psychosis: Epidemiologic EvidenceBiological Psychiatry, 2016
- Meta-analysis of the Association Between the Level of Cannabis Use and Risk of PsychosisSchizophrenia Bulletin, 2016
- LD Score regression distinguishes confounding from polygenicity in genome-wide association studiesNature Genetics, 2015
- A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviorsSchizophrenia Research, 2005
- CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish ConscriptsThe Lancet, 1987